Cargando…
An Inter‐Cooperative Biohybrid Platform to Enable Tumor Ablation and Immune Activation
A biohybrid therapeutic system, consisting of responsive materials and living microorganisms with inter‐cooperative effects, is designed and investigated for tumor treatment. In this biohybrid system, S(2)O(3) (2−)‐intercalated CoFe layered double hydroxides (LDH) are integrated at the surface of Ba...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10427385/ https://www.ncbi.nlm.nih.gov/pubmed/37314157 http://dx.doi.org/10.1002/advs.202207194 |
_version_ | 1785090227108315136 |
---|---|
author | Li, Feiyu Chu, Qiang Hu, Zefeng Lu, Zijie Fang, Chao Han, Gaorong Fu, Yike Li, Xiang |
author_facet | Li, Feiyu Chu, Qiang Hu, Zefeng Lu, Zijie Fang, Chao Han, Gaorong Fu, Yike Li, Xiang |
author_sort | Li, Feiyu |
collection | PubMed |
description | A biohybrid therapeutic system, consisting of responsive materials and living microorganisms with inter‐cooperative effects, is designed and investigated for tumor treatment. In this biohybrid system, S(2)O(3) (2−)‐intercalated CoFe layered double hydroxides (LDH) are integrated at the surface of Baker's yeasts. Under the tumor microenvironment, functional interactions between yeast and LDH are effectively triggered, resulting in S(2)O(3) (2−) release, H(2)S production, and in‐situ generation of highly catalytic agents. Meanwhile, the degradation of LDH in the tumor microenvironment induces the exposure of the surface antigen of yeast, leading to effective immune activation at the tumor site. By virtue of the inter‐cooperative phenomena, this biohybrid system exhibits significant efficacy in tumor ablation and strong inhibition of recurrence. This study has potentially offered an alternative concept by utilizing the metabolism of living microorganisms and materials in exploring effective tumor therapeutics. |
format | Online Article Text |
id | pubmed-10427385 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-104273852023-08-17 An Inter‐Cooperative Biohybrid Platform to Enable Tumor Ablation and Immune Activation Li, Feiyu Chu, Qiang Hu, Zefeng Lu, Zijie Fang, Chao Han, Gaorong Fu, Yike Li, Xiang Adv Sci (Weinh) Research Articles A biohybrid therapeutic system, consisting of responsive materials and living microorganisms with inter‐cooperative effects, is designed and investigated for tumor treatment. In this biohybrid system, S(2)O(3) (2−)‐intercalated CoFe layered double hydroxides (LDH) are integrated at the surface of Baker's yeasts. Under the tumor microenvironment, functional interactions between yeast and LDH are effectively triggered, resulting in S(2)O(3) (2−) release, H(2)S production, and in‐situ generation of highly catalytic agents. Meanwhile, the degradation of LDH in the tumor microenvironment induces the exposure of the surface antigen of yeast, leading to effective immune activation at the tumor site. By virtue of the inter‐cooperative phenomena, this biohybrid system exhibits significant efficacy in tumor ablation and strong inhibition of recurrence. This study has potentially offered an alternative concept by utilizing the metabolism of living microorganisms and materials in exploring effective tumor therapeutics. John Wiley and Sons Inc. 2023-06-14 /pmc/articles/PMC10427385/ /pubmed/37314157 http://dx.doi.org/10.1002/advs.202207194 Text en © 2023 The Authors. Advanced Science published by Wiley‐VCH GmbH https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Articles Li, Feiyu Chu, Qiang Hu, Zefeng Lu, Zijie Fang, Chao Han, Gaorong Fu, Yike Li, Xiang An Inter‐Cooperative Biohybrid Platform to Enable Tumor Ablation and Immune Activation |
title | An Inter‐Cooperative Biohybrid Platform to Enable Tumor Ablation and Immune Activation |
title_full | An Inter‐Cooperative Biohybrid Platform to Enable Tumor Ablation and Immune Activation |
title_fullStr | An Inter‐Cooperative Biohybrid Platform to Enable Tumor Ablation and Immune Activation |
title_full_unstemmed | An Inter‐Cooperative Biohybrid Platform to Enable Tumor Ablation and Immune Activation |
title_short | An Inter‐Cooperative Biohybrid Platform to Enable Tumor Ablation and Immune Activation |
title_sort | inter‐cooperative biohybrid platform to enable tumor ablation and immune activation |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10427385/ https://www.ncbi.nlm.nih.gov/pubmed/37314157 http://dx.doi.org/10.1002/advs.202207194 |
work_keys_str_mv | AT lifeiyu anintercooperativebiohybridplatformtoenabletumorablationandimmuneactivation AT chuqiang anintercooperativebiohybridplatformtoenabletumorablationandimmuneactivation AT huzefeng anintercooperativebiohybridplatformtoenabletumorablationandimmuneactivation AT luzijie anintercooperativebiohybridplatformtoenabletumorablationandimmuneactivation AT fangchao anintercooperativebiohybridplatformtoenabletumorablationandimmuneactivation AT hangaorong anintercooperativebiohybridplatformtoenabletumorablationandimmuneactivation AT fuyike anintercooperativebiohybridplatformtoenabletumorablationandimmuneactivation AT lixiang anintercooperativebiohybridplatformtoenabletumorablationandimmuneactivation AT lifeiyu intercooperativebiohybridplatformtoenabletumorablationandimmuneactivation AT chuqiang intercooperativebiohybridplatformtoenabletumorablationandimmuneactivation AT huzefeng intercooperativebiohybridplatformtoenabletumorablationandimmuneactivation AT luzijie intercooperativebiohybridplatformtoenabletumorablationandimmuneactivation AT fangchao intercooperativebiohybridplatformtoenabletumorablationandimmuneactivation AT hangaorong intercooperativebiohybridplatformtoenabletumorablationandimmuneactivation AT fuyike intercooperativebiohybridplatformtoenabletumorablationandimmuneactivation AT lixiang intercooperativebiohybridplatformtoenabletumorablationandimmuneactivation |